1. 000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102). (1st September 2005) Authors: du Bois, A.; Schroeder, W.; Jelic, S.; Weber, B.; Sehouli, J.; Keern, J.; Priou, F.; Huober, J.; Railing, M.; Ray-Coquard, I.; Heilmann, V.; Surges, A.; Pfisterer, J.; Gropp, M.; Staehle, A.; Wimberger, P.; Jackisch, C.; Mueller, H. H. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer. (September 2015) Authors: Campone, M.; Ferrero, J.M.; Gunzer, K.; Priou, F.; Dubreuil, P.; Mansfield, C.; Moussy, A.; Hermine, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2621 Everolimus in advanced urothelial carcinoma (UC) pretreated with at least 2 lines of chemotherapy (CT) the afinivest study. (September 2015) Authors: Theodore, C.; Gravisd-Mescam, G.; Meunier, J.; Guillot, A.; Voog, E.; Aubert, D.; Priou, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗